202 related articles for article (PubMed ID: 16260151)
1. Purification and characterization of a recombinant anti-angiogenic kringle fragment expressed in Escherichia coli: Purification and characterization of a tri-kringle fragment from human apolipoprotein (a) (kringle IV (9)-kringle IV (10)-kringle V).
Kang KY; Kim SG; Kim WK; You HK; Kim YJ; Lee JH; Jung KH; Kim CW
Protein Expr Purif; 2006 Jan; 45(1):216-25. PubMed ID: 16260151
[TBL] [Abstract][Full Text] [Related]
2. Recombinant gene expression and 1H NMR characteristics of the kringle (2 + 3) supermodule: spectroscopic/functional individuality of plasminogen kringle domains.
Söhndel S; Hu CK; Marti D; Affolter M; Schaller J; Llinás M; Rickli EE
Biochemistry; 1996 Feb; 35(7):2357-64. PubMed ID: 8652577
[TBL] [Abstract][Full Text] [Related]
3. Secreted human apolipoprotein(a) kringle IV-10 and kringle V inhibit angiogenesis and xenografted tumor growth.
Shen L; Zhu X; Wang Y; Zeng W; Wu G; Xue H; Chen B
Biol Chem; 2008 Feb; 389(2):135-41. PubMed ID: 18163888
[TBL] [Abstract][Full Text] [Related]
4. High level expression of kringle 5 fragment of plasminogen in Pichia pastoris.
Zhou Y; Zheng Q; Gao J; Gu J
Biotechnol Lett; 2005 Feb; 27(3):167-71. PubMed ID: 15717125
[TBL] [Abstract][Full Text] [Related]
5. Expression of recombinant kringle 1-5 domains of human plasminogen by a prokaryote expression system.
Hou WH; Fang T; Chai YR; Wang TY; Wang JM; Xue LX
Protein Expr Purif; 2006 May; 47(1):93-8. PubMed ID: 16510293
[TBL] [Abstract][Full Text] [Related]
6. Antiangiogenic kringles derived from human plasminogen and apolipoprotein(a) inhibit fibrinolysis through a mechanism that requires a functional lysine-binding site.
Ahn JH; Lee HJ; Lee EK; Yu HK; Lee TH; Yoon Y; Kim SJ; Kim JS
Biol Chem; 2011 Apr; 392(4):347-56. PubMed ID: 21194375
[TBL] [Abstract][Full Text] [Related]
7. Characterization and biological activities of recombinant human plasminogen kringle 1-3 produced in Escherichia coli.
You WK; So SH; Sohn YD; Lee H; Park DH; Chung SI; Chung KH
Protein Expr Purif; 2004 Jul; 36(1):1-10. PubMed ID: 15177278
[TBL] [Abstract][Full Text] [Related]
8. Purification of a bioactive recombinant human Reg IV expressed in Escherichia coli.
Hu G; Shen J; Cheng L; Xiang D; Zhang Z; He M; Lu H; Zhu S; Wu M; Yu Y; Wang X; Han W
Protein Expr Purif; 2010 Feb; 69(2):186-90. PubMed ID: 19699332
[TBL] [Abstract][Full Text] [Related]
9. Crystallization of antiangiogenic Kringle V derived from human apolipoprotein A: crystallization applied to purification and formulation.
Kang KY; Park JH; Lim IH; Kim SG; Park SH; Kim WK; Hong JW; You HK; Jung KH; Kim CW
Biosci Biotechnol Biochem; 2006 Apr; 70(4):916-25. PubMed ID: 16636459
[TBL] [Abstract][Full Text] [Related]
10. Refolding and purification of recombinant human PDE7A expressed in Escherichia coli as inclusion bodies.
Richter W; Hermsdorf T; Kronbach T; Dettmer D
Protein Expr Purif; 2002 Jun; 25(1):138-48. PubMed ID: 12071709
[TBL] [Abstract][Full Text] [Related]
11. Apo(a)-kringle IV-type 6: expression in Escherichia coli, purification and in vitro refolding.
Hrzenjak A; Frank S; Maderegger B; Sterk H; Kostner GM
Protein Eng; 2000 Sep; 13(9):661-6. PubMed ID: 11054461
[TBL] [Abstract][Full Text] [Related]
12. Refolding, purification, and activation of miniplasminogen and microplasminogen isolated from E. coli inclusion bodies.
Medynski D; Tuan M; Liu W; Wu S; Lin X
Protein Expr Purif; 2007 Apr; 52(2):395-402. PubMed ID: 17126563
[TBL] [Abstract][Full Text] [Related]
13. Renaturation, purification and characterization of streptokinase expressed as inclusion body in recombinant E. coli.
Cherish Babu PV; Srinivas VK; Krishna Mohan V; Krishna E
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jan; 861(2):218-26. PubMed ID: 17981102
[TBL] [Abstract][Full Text] [Related]
14. Purification and refolding of Escherichia coli-expressed recombinant human interleukin-2.
Esfandiar S; Hashemi-Najafabadi S; Shojaosadati SA; Sarrafzadeh SA; Pourpak Z
Biotechnol Appl Biochem; 2010 Apr; 55(4):209-14. PubMed ID: 20236092
[TBL] [Abstract][Full Text] [Related]
15. Recombinant human epidermal growth factor inclusion body solubilization and refolding at large scale using expanded-bed adsorption chromatography from Escherichia coli.
Sharma K; Babu PV; Sasidhar P; Srinivas VK; Mohan VK; Krishna E
Protein Expr Purif; 2008 Jul; 60(1):7-14. PubMed ID: 18430585
[TBL] [Abstract][Full Text] [Related]
16. On-column refolding and purification of recombinant human interleukin-1 receptor antagonist (rHuIL-1ra) expressed as inclusion body in Escherichia coli.
Tan H; Dan G; Gong H; Cao L
Biotechnol Lett; 2005 Aug; 27(16):1177-82. PubMed ID: 16158260
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and expression of a gene from kringle-2 domain of tissue plasminogen activator in E. coli.
Hua ZC; Fu HL; Chen YH; Yu RR; Wang J; Zhu DX
Sci China B; 1994 Jun; 37(6):667-76. PubMed ID: 7917003
[TBL] [Abstract][Full Text] [Related]
18. Bacterial fermentation of recombinant major wasp allergen Antigen 5 using oxygen limiting growth conditions improves yield and quality of inclusion bodies.
Kischnick S; Weber B; Verdino P; Keller W; Sanders EA; Anspach FB; Fiebig H; Cromwell O; Suck R
Protein Expr Purif; 2006 Jun; 47(2):621-8. PubMed ID: 16495080
[TBL] [Abstract][Full Text] [Related]
19. Production and purification of TAL6003: a novel version of the protease plasmin.
Aguda R; Caronna A; Hunt J; Koepf E; Lindsay M; Miller C; Rebbeor J; Silverstein R; Stokes K; Zimmerman T
Protein Expr Purif; 2013 Mar; 88(1):41-6. PubMed ID: 23220455
[TBL] [Abstract][Full Text] [Related]
20. Recombinant kringle IV-10 modules of human apolipoprotein(a): structure, ligand binding modes, and biological relevance.
Mochalkin I; Cheng B; Klezovitch O; Scanu AM; Tulinsky A
Biochemistry; 1999 Feb; 38(7):1990-8. PubMed ID: 10026282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]